-
Mashup Score: 0Celldex drug reduces chronic hive activity, but patient discontinuations raise questions - 17 hour(s) ago
Celldex Therapeutics reported that its medicine for a condition that causes chronic hives reduced hive activity and, notably, did not raise any safety concerns.
Source: www.statnews.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 15T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels - 21 hour(s) ago
How T cells are recruited to brain tumors from the blood remains unclear. Messmer et al. identify peritumoral venous vessels (PVVs) as key structures for T cell recruitment to melanoma brain tumors. PVVs are the sites of T cell extravasation and facilitated rapid T cell migration under immune checkpoint inhibition. T cell recruitment and antitumor immunity were dependent on ICAM-1.
Source: www.cell.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 59Maintenance of X chromosome inactivation after T cell activation requires NF-κB signaling - 1 day(s) ago
X chromosome inactivation maintenance, including Xist RNA localization to the inactive X, requires canonical NF-κB signaling in T cells.
Source: www.science.orgCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 7
Orismilast outperformed placebo in the treatment of moderate to severe atopic dermatitis in adults, according to a poster presented at the European Academy of Dermatology and Venereology Congress. “Orismilast is a potent, selective phosphodiesterase 4 (PDE4)-B and -D inhibitor, which showed significant efficacy in a phase 2b psoriasis study,” Eric L. Simpson, MD, MCR, Frances J.
Source: www.healio.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 1Murine parainfluenza virus persists in lung innate immune cells sustaining chronic lung pathology - 1 day(s) ago
Nature Microbiology – Murine parainfluenza virus (Sendai) persists and imprints lung innate immune cells, leaving long-lasting transcriptomic alterations associated with type-2 inflammation and…
Source: www.nature.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 5Nobel Laureates - The American Association of Immunologists - 2 day(s) ago
Nobel Prize winning members of The American Association of Immunologists
Source: www.aai.orgCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 0Donny & Marie Show - Star Wars Special (1977) - 2 day(s) ago
The finale of this show was a tribute to Star Wars. Donny Osmond played Luke, his sister Marie played Luke’s sister Leia (spoilers!) and Kris Kristofferson w…
Source: www.youtube.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 6Avoid the Danger of Anaphylaxis this Halloween | AAAAI - 2 day(s) ago
The AAAAI offers tips written and reviewed by experts on allergies on avoiding the danger of anaphylaxis this Halloween.
Source: www.aaaai.orgCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 151Contents | Science Immunology 9, 100 - 2 day(s) ago
ONLINE COVER Sex-Biased Gene Regulation in T Cells. In females, X chromosome inactivation (XCI) represses gene expression from one X chromosome to balance gene dosage between the sexes. This process is controlled by the long noncoding RNA Xist, which coats the inactive X chromosome and promotes epigenetic gene silencing. Forsyth et al. studied XCI in mouse and human T cells, a process that is much more dynamic in T cells than in most other somatic cells. NF-κB signaling downstream of the T cell receptor
Source: www.science.orgCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 80
How T cells are recruited to brain tumors from the blood remains unclear. Messmer et al. identify peritumoral venous vessels (PVVs) as key structures for T cell recruitment to melanoma brain tumors. PVVs are the sites of T cell extravasation and facilitated rapid T cell migration under immune checkpoint inhibition. T cell recruitment and antitumor immunity were dependent on ICAM-1.
Source: www.cell.comCategories: General Medicine News, Allergy-ImmunologyTweet
https://t.co/0iazR6CZao new chronic urticaria therapy: 25% of patients who started the study on barzolvolimab stopped treatment during the trial, changes in hair and skin color reported